Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kevin Gruffydd-Jones. (2019) Unmet needs in asthma. Therapeutics and Clinical Risk Management 15, pages 409-421.
Read now
Read now
Laren D Tan, Brett Schaeffer & Abdullah Alismail. (2019) Parasitic (Helminthic) Infection While on Asthma Biologic Treatment: Not Everything Is What It Seems. Journal of Asthma and Allergy 12, pages 415-420.
Read now
Read now
Diego Jose Maselli, Linda Rogers & Jay I Peters. (2018) Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use. Therapeutics and Clinical Risk Management 14, pages 2059-2068.
Read now
Read now
Luisa Brussino, Paolo Solidoro & Giovanni Rolla. (2017) Is it severe asthma or asthma with severe comorbidities?. Journal of Asthma and Allergy 10, pages 303-305.
Read now
Read now
Articles from other publishers (17)
Emmanuel Oshiogwe Okwuofu, Audrey Chee Hui Yong, Jonathan Chee Woei Lim & Johnson Stanslas. (2022) Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma. Pharmacological Research 181, pages 106280.
Crossref
Crossref
Shang Yan, Huang Haidong, Zhu Chengjie, Wang Qin, Wolfgang Hohenforst-Schmidt, Lutz Freitag, Kosmas Tsakiridis, Paul Zarogoulidis, Christos Arnaoutoglou, Aris Ioannidis & Bai Chong. (2022) Tentative study on radial endobronchial ultrasonography evaluating airway wall thickness before and after bronchial thermoplasty. Respiratory Medicine Case Reports 36, pages 101571.
Crossref
Crossref
Arianna Cafarotti, Alessandro Fiocchi & Stefania Arasi. (2021) Biologics as treatment options for anaphylaxis. Current Opinion in Allergy & Clinical Immunology 21:5, pages 455-464.
Crossref
Crossref
Francesco Menzella, Giulia Ghidoni, Carla Galeone, Silvia Capobelli, Chiara Scelfo & Nicola Cosimo Facciolongo. (2021) Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab. Biomedicines 9:4, pages 348.
Crossref
Crossref
Giovanna Elisiana Carpagnano, Emanuela Resta, Massimiliano Povero, Corrado Pelaia, Mariella D’Amato, Nunzio Crimi, Nicola Scichilone, Giulia Scioscia, Onofrio Resta, Cecilia Calabrese, Girolamo Pelaia & Maria Pia Foschino Barbaro. (2021) Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma. Scientific Reports 11:1.
Crossref
Crossref
Elisa Lewington-Gower, Ley Chan & Anand Shah. (2021) Review of current and future therapeutics in ABPA. Therapeutic Advances in Chronic Disease 12, pages 204062232110470.
Crossref
Crossref
Sujoy Khan. (2020) Managing patients with Th2 severe refractory asthma with bronchial thermoplasty. Journal of Precision Respiratory Medicine 3:1, pages 21-22.
Crossref
Crossref
Giovanna Elisiana Carpagnano, Francesco Sessa, Giulia Scioscia, Donato Lacedonia, Maria Pia Foschino, Maria Pia Venuti, Antonio Ivano Triggiani, Anna Valenzano, Onofrio Resta, Giuseppe Cibelli & Giovanni Messina. (2020) Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study. Frontiers in Pharmacology 10.
Crossref
Crossref
S. D. Keir-Rudman, Y. Riffo-Vasquez, C. L. Robaina Cabrera & C. P. Page. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
14
.
Arjun Mohan, Jon Grace, Anne Mainardi, Geoffrey Chupp & Njira Lugogo. 2020. Difficult To Treat Asthma. Difficult To Treat Asthma
123
153
.
MA Al Ammari. (2019) Biologic therapy in severe asthma: An update. Archives of Asthma, Allergy and Immunology 3:1, pages 003-009.
Crossref
Crossref
Tomohiro Ichikawa, Alice Panariti, Severine Audusseau, Andrea Karen Mogas, Ronald Olivenstein, Jamila Chakir, Michel Laviolette, Zoulfia Allakhverdi, Saba Al Heialy, James G. Martin & Qutayba Hamid. (2019) Effect of bronchial thermoplasty on structural changes and inflammatory mediators in the airways of subjects with severe asthma. Respiratory Medicine 150, pages 165-172.
Crossref
Crossref
Anne S. Mainardi, Mario Castro & Geoffrey Chupp. (2019) Bronchial Thermoplasty. Clinics in Chest Medicine 40:1, pages 193-207.
Crossref
Crossref
Viktoria Grammatopoulou, Coimbatore V. Praveena & Vishnu S. Sunkaraneni. (2019) Optimising Medical Management in CRS. Current Otorhinolaryngology Reports 7:1, pages 87-97.
Crossref
Crossref
S. K. Zyryanov & O. I. Butranova. (2018) Genetically engineered drugs for treatment of bronchial asthma: recent achievements. Russian Pulmonology 28:5, pages 584-601.
Crossref
Crossref
Takeshi Terashima, Taro Shinozaki, Eri Iwami, Takahiro Nakajima & Tatsu Matsuzaki. (2018) A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab. BMC Pulmonary Medicine 18:1.
Crossref
Crossref
Niharika Rath, Nikita Raje & Lanny Rosenwasser. (2018) Immunoglobulin E as a Biomarker in Asthma. Immunology and Allergy Clinics of North America 38:4, pages 587-597.
Crossref
Crossref